PL447494A1 - Szczep Lactiplantibacillus plantarum PL6 i zastosowanie szczepu Lactiplantibacillus plantarum PL6 - Google Patents

Szczep Lactiplantibacillus plantarum PL6 i zastosowanie szczepu Lactiplantibacillus plantarum PL6

Info

Publication number
PL447494A1
PL447494A1 PL447494A PL44749424A PL447494A1 PL 447494 A1 PL447494 A1 PL 447494A1 PL 447494 A PL447494 A PL 447494A PL 44749424 A PL44749424 A PL 44749424A PL 447494 A1 PL447494 A1 PL 447494A1
Authority
PL
Poland
Prior art keywords
strain
application
lactiplantibacillus plantarum
microorganisms
lactiplantibacillus
Prior art date
Application number
PL447494A
Other languages
English (en)
Other versions
PL248297B1 (pl
Inventor
Magdalena Strus
Piotr Heczko
Original Assignee
Prolab Spółka Z Ograniczoną Odpowiedzialnością Spółka Komandytowa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolab Spółka Z Ograniczoną Odpowiedzialnością Spółka Komandytowa filed Critical Prolab Spółka Z Ograniczoną Odpowiedzialnością Spółka Komandytowa
Priority to PL447494A priority Critical patent/PL248297B1/pl
Publication of PL447494A1 publication Critical patent/PL447494A1/pl
Publication of PL248297B1 publication Critical patent/PL248297B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest szczep Lactiplantibacillus plantarum oznaczony symbolem PL6 zdeponowany, zgodnie z traktatem budapeszteńskim o międzynarodowym uznawaniu depozytu drobnoustrojów dla celów postępowania patentowego, w Polskiej Kolekcji Mikroorganizmów (PCM) w Instytucie Immunologii i Terapii Doświadczalnej Polskiej Akademii Nauk we Wrocławiu w dniu 13 sierpnia 2018 roku pod numerem B/00162 posiadający sekwencję genomową przedstawioną w załączniku nr 1. Szczep oprócz właściwości probiotycznych posiada zdolność do przetrwania w warunkach ograniczonego dostępu do źródeł energii, czyli głodzenia. Zgłoszenie obejmuje też zastosowanie szczepu Lactiplantibacillus plantarum PL6, które obejmuje wytwarzanie produktów żywnościowych, suplementów diety, a także wód mineralnych, soków i innych napojów w formie probiotyku lub postbiotyku. Szczep przeznaczony jest też do stosowania w stanach zaburzenia mikrobioty jelitowej po leczeniu antybiotykami, w rekonwalescencji po chorobach przewodu pokarmowego, w zaparciach, a także zapobiegawczo w celu ochrony przed biegunkami i regulowania funkcji przewodu pokarmowego u ludzi zdrowych, oraz do stosowania w jamie ustnej i drogach rodnych w celu przywrócenia prawidłowej flory po zakażeniach bakteryjnych, grzybiczych oraz po leczeniu antybiotykowym w celu odbudowy prawidłowej mikrobioty.
PL447494A 2024-01-11 2024-01-11 Szczep Lactiplantibacillus plantarum PL6 i zastosowanie szczepu Lactiplantibacillus plantarum PL6 PL248297B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL447494A PL248297B1 (pl) 2024-01-11 2024-01-11 Szczep Lactiplantibacillus plantarum PL6 i zastosowanie szczepu Lactiplantibacillus plantarum PL6

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL447494A PL248297B1 (pl) 2024-01-11 2024-01-11 Szczep Lactiplantibacillus plantarum PL6 i zastosowanie szczepu Lactiplantibacillus plantarum PL6

Publications (2)

Publication Number Publication Date
PL447494A1 true PL447494A1 (pl) 2025-07-14
PL248297B1 PL248297B1 (pl) 2025-11-24

Family

ID=96344861

Family Applications (1)

Application Number Title Priority Date Filing Date
PL447494A PL248297B1 (pl) 2024-01-11 2024-01-11 Szczep Lactiplantibacillus plantarum PL6 i zastosowanie szczepu Lactiplantibacillus plantarum PL6

Country Status (1)

Country Link
PL (1) PL248297B1 (pl)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL410757A1 (pl) * 2014-12-23 2016-07-04 Prolab Spółka Z Ograniczoną Odpowiedzialnością, Spółka Komandytowa Nowy szczep Lactobacillus plantarum PL3, jego metabolit oraz zastosowanie szczepu Lactobacillus plantarum PL3 i jego metabolitu
PL412093A1 (pl) * 2015-04-22 2016-10-24 Miralex Spółka Z Ograniczoną Odpowiedzialnością Zastosowanie kompozycji szczepów z rodzaju Lactobacillus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL410757A1 (pl) * 2014-12-23 2016-07-04 Prolab Spółka Z Ograniczoną Odpowiedzialnością, Spółka Komandytowa Nowy szczep Lactobacillus plantarum PL3, jego metabolit oraz zastosowanie szczepu Lactobacillus plantarum PL3 i jego metabolitu
PL412093A1 (pl) * 2015-04-22 2016-10-24 Miralex Spółka Z Ograniczoną Odpowiedzialnością Zastosowanie kompozycji szczepów z rodzaju Lactobacillus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FONSECA, H.C., MELO, D.D., RAMOS, C.L. ET AL.: "Braz J Microbiol 52, 2307–2317 (2021).", LACTIPLANTIBACILLUS PLANTARUM CCMA 0743 AND LACTICASEIBACILLUS PARACASEI SUBSP. PARACASEI LBC-81 METABOLISM DURING THE SINGLE AND MIXED FERMENTATION OF TROPICAL FRUIT JUICES., DOI: https://doi.org/10.1007/s42770-021-00628-7 *
ZENG Y, FADAAK A, ALOMEIR N, WU TT, RUSTCHENKO E, QING S, BAO J, GILBERT C, XIAO J: "Front. Cell. Infect. Microbiol., 2022, 12:872012", LACTOBACILLUS PLANTARUM DISRUPTS S. MUTANS–C. ALBICANS CROSS-KINGDOM BIOFILMS, DOI: 10.3389/fcimb.2022.872012 *

Also Published As

Publication number Publication date
PL248297B1 (pl) 2025-11-24

Similar Documents

Publication Publication Date Title
KR102434323B1 (ko) 세균질증의 예방적 및/또는 치료적 치료에서 사용하기 위한 락트산 박테리아를 포함하는 조성물
EP3681470B1 (en) Lactobacillus casei or lactobacillus paracasei for use in the treatment of clostridium difficile infections
Sarowska et al. The therapeutic effect of probiotic bacteria on gastrointestinal diseases
Chen et al. Oral administration of a combination of select lactic acid bacteria strains to reduce the Salmonella invasion and inflammation of broiler chicks
Adams The probiotic paradox: live and dead cells are biological response modifiers
KR101178217B1 (ko) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
Barbés et al. Potential role of lactobacilli as prophylactic agents against genital pathogens
MX2013005371A (es) Micro-organismos probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.
US20150079041A1 (en) Bacterial composition and its use
RU2713414C2 (ru) Композиция для применения в лечении или предупреждении вирусных или бактериальных инфекций у субъекта, проходящего противоопухолевую химиотерапию, лечение лейкоза или лечение СПИД, содержащая l.reuteri ler03 и/или l.salivarius ls06
JP7126004B2 (ja) 組成物及びその使用
AU2020101490A4 (en) Lactobacillus fermentum strain v3 and its efficacies of intestinal microflora regulation, anti-inflammation and cancer prevention
KR20080075971A (ko) 프로바이오틱스 복합 제제
KR20080081486A (ko) 신규 유산균 균주 및 이를 포함하는 유산균 제제
CN113631174A (zh) 用于预防和/或治疗慢性炎症性疾病和/或炎症性胃肠疾病和/或癌症的克里斯滕森菌科细菌
JP7497929B2 (ja) 新規なラクトバチルス属菌株及びその用途
Lamine et al. Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats
EP2637677B1 (en) Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP3377083A1 (en) Compositions with a synergistic action between a mucoadherent gelling complex against the passage of antigens, and immunomodulatory anti-il17 bacteria for use in the treatment of un¢ related autoimmune and neurodegenerative diseases.
PL447494A1 (pl) Szczep Lactiplantibacillus plantarum PL6 i zastosowanie szczepu Lactiplantibacillus plantarum PL6
EP4406542A1 (en) Treatment of gut inflammatory diseases
Rathnapraba et al. Effect of dietary supplementation of probiotic and BMD on the growth performance of broiler chickens challenged with Clostridium perfringens induced necrotic enteritis
Michel et al. Colonic infusion with Propionibacterium acidipropionici reduces severity of chemically-induced colitis in rats
JP7286592B2 (ja) 下痢、食欲不振、および体重維持を改善するための化学療法剤の補助剤としてのストレプトコッカス・サーモフィルス株ｓｔ４の組成物
Zakari et al. EVALUATION OF THE ANTIULCER AND ANTIDIARRHEAL POTENTIAL OF LACTIC ACID BACTERIA ISOLATED FROM YOGURT IN ULCER AND DIARRHEA INDUCED IN WISTAR RATS